The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function

被引:0
|
作者
L. Francisco Lorenzo-Martín
Mauricio Menacho-Márquez
Natalia Fernández-Parejo
Sonia Rodríguez-Fdez
Gloria Pascual
Antonio Abad
Piero Crespo
Mercedes Dosil
Salvador A. Benitah
Xosé R. Bustelo
机构
[1] Molecular Mechanisms of Cancer Program,
[2] Centro de Investigación del Cáncer,undefined
[3] Consejo Superior de Investigaciones Científicas (CSIC)-University of Salamanca,undefined
[4] Instituto de Biología Molecular y Celular del Cáncer,undefined
[5] CSIC-University of Salamanca,undefined
[6] Centro de Investigación Biomédica en Red de Cáncer (CIBERONC),undefined
[7] Institut de Reserca Biomédica,undefined
[8] Instituto de Biomedicina y Biotecnología de Cantabria,undefined
[9] CSIC-University of Cantabria,undefined
来源
Oncogene | 2022年 / 41卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
It is known that Rho GTPases control different aspects of the biology of skin stem cells (SSCs). However, little information is available on the role of their upstream regulators under normal and tumorigenic conditions in this process. To address this issue, we have used here mouse models in which the activity of guanosine nucleotide exchange factors of the Vav subfamily has been manipulated using both gain- and loss-of-function strategies. These experiments indicate that Vav2 and Vav3 regulate the number, functional status, and responsiveness of hair follicle bulge stem cells. This is linked to gene expression programs related to the reinforcement of the identity and the quiescent state of normal SSCs. By contrast, in the case of cancer stem cells, they promote transcriptomal programs associated with the identity, activation state, and cytoskeletal remodeling. These results underscore the role of these Rho exchange factors in the regulation of normal and tumor epidermal stem cells.
引用
收藏
页码:3341 / 3354
页数:13
相关论文
共 50 条
  • [1] The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function
    Francisco Lorenzo-Martin, L.
    Menacho-Marquez, Mauricio
    Fernandez-Parejo, Natalia
    Rodriguez-Fdez, Sonia
    Pascual, Gloria
    Abad, Antonio
    Crespo, Piero
    Dosil, Mercedes
    Benitah, Salvador A.
    Bustelo, Xose R.
    ONCOGENE, 2022, 41 (24) : 3341 - 3354
  • [2] Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors
    Perretta-Tejedor, Nuria
    Fernandez-Mateos, Javier
    Garcia-Ortiz, Luis
    Gomez-Marcos, Manuel A.
    Recio-Rodriguez, Jose I.
    Agudo-Conde, Cristina
    Rodriguez-Sanchez, Emiliano
    Morales, Ana I.
    Lopez-Hernandez, Francisco J.
    Lopez-Novoa, Jose M.
    Gonzalez-Sarmiento, Rogelio
    Martinez-Salgado, Carlos
    SCIENTIFIC REPORTS, 2017, 7
  • [3] Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors
    Nuria Perretta-Tejedor
    Javier Fernández-Mateos
    Luis García-Ortiz
    Manuel A. Gómez-Marcos
    José I. Recio-Rodríguez
    Cristina Agudo-Conde
    Emiliano Rodriguez-Sánchez
    Ana I. Morales
    Francisco J. López-Hernández
    José M. López-Novoa
    Rogelio González-Sarmiento
    Carlos Martínez-Salgado
    Scientific Reports, 7
  • [4] The Rho Exchange Factors Vav2 and Vav3 Favor Skin Tumor Initiation and Promotion by Engaging Extracellular Signaling Loops
    Menacho-Marquez, Mauricio
    Garcia-Escudero, Ramon
    Ojeda, Virginia
    Abad, Antonio
    Delgado, Pilar
    Costa, Clotilde
    Ruiz, Sergio
    Alarcon, Balbino
    Paramio, Jesus M.
    Bustelo, Xose R.
    PLOS BIOLOGY, 2013, 11 (07)
  • [5] Recognition and activation of rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors
    Heo, J
    Thapar, R
    Campbell, SL
    BIOCHEMISTRY, 2005, 44 (17) : 6573 - 6585
  • [6] The Rho Exchange Factors Vav2 and Vav3 Control a Lung Metastasis-Specific Transcriptional Program in Breast Cancer Cells
    Citterio, Carmen
    Menacho-Marquez, Mauricio
    Garcia-Escudero, Ramon
    Larive, Romain M.
    Barreiro, Olga
    Sanchez-Madrid, Francisco
    Paramio, Jesus M.
    Bustelo, Xose R.
    SCIENCE SIGNALING, 2012, 5 (244)
  • [7] Correction: Corrigendum: Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors
    Nuria Perretta-Tejedor
    Javier Fernández-Mateos
    Luis García-Ortiz
    Manuel A. Gómez-Marcos
    José I. Recio-Rodríguez
    Cristina Agudo-Conde
    Emiliano Rodriguez-Sánchez
    Ana I. Morales
    Francisco J. López-Hernández
    José M. López-Novoa
    Rogelio González-Sarmiento
    Carlos Martínez-Salgado
    Scientific Reports, 8
  • [8] Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors (vol 7, 2017)
    Perretta-Tejedor, Nuria
    Fernandez-Mateos, Javier
    Garcia-Ortiz, Luis
    Gomez-Marcos, Manuel A.
    Recio-Rodriguez, Jose I.
    Agudo-Conde, Cristina
    Rodriguez-Sanchez, Emiliano
    Morales, Ana I.
    Lopez-Hernandez, Francisco J.
    Lopez-Novoa, Jose M.
    Gonzalez-Sarmiento, Rogelio
    Martinez-Salgado, Carlos
    SCIENTIFIC REPORTS, 2018, 8
  • [9] Major transcript variants of VAV3, a new member of the VAV family of guanine nucleotide exchange factors
    Trenkle, T
    McClelland, M
    Adlkofer, K
    Welsh, J
    GENE, 2000, 245 (01) : 139 - 149
  • [10] VAV2 and VAV3 as Candidate Disease Genes for Spontaneous Glaucoma in Mice and Humans
    Fujikawa, Keiko
    Iwata, Takeshi
    Inoue, Kaoru
    Akahori, Masakazu
    Kadotani, Hanako
    Fukaya, Masahiro
    Watanabe, Masahiko
    Chang, Qing
    Barnett, Edward M.
    Swat, Wojciech
    PLOS ONE, 2010, 5 (02):